22157.jpg
Global Clinical Oncology Next Generation Sequencing Markets to 2030: Ion Semiconductor, Pyro, Synthesis, Real Time, Ligation, Reversible Dye Termination, & Nano-Pore Sequencing
May 06, 2021 05:33 ET | Research and Markets
Dublin, May 06, 2021 (GLOBE NEWSWIRE) -- The "Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to...
Arvinas Signs Lease for New Space Within Downtown Crossing Development in New Haven
May 04, 2021 14:52 ET | Arvinas Inc.
NEW HAVEN, Conn., May 04, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
LOGO.jpg
QSAM Biosciences Announces Submission of IND Application for CycloSam® with FDA
May 04, 2021 09:00 ET | QSAM Biosciences Inc.
Austin, TX, May 04, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases, announced...
arvinas logo.jpg
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 04, 2021 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., May 04, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted protein degradation, today...
FBI LOGO TM.png
Breast Cancer Therapeutics Market Size 2021 | Is Projected to Reach USD 55.27 Billion by 2027 with a CAGR of 13.1%
May 04, 2021 04:18 ET | Fortune Business Insights
Pune, India, May 04, 2021 (GLOBE NEWSWIRE) -- According to the report, Breast Cancer Therapeutics market size is projected to reach USD 55.27 Billion by 2027. Breast Cancer Therapeutics Market was...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Project With Huntsman Cancer Institute Researcher to Investigate Potential Effects of Lasofoxifene on ESR1 Mutations in Endometrial Cancer
April 21, 2021 09:44 ET | Sermonix Pharmaceuticals LLC
COLUMBUS, Ohio, April 21, 2021 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to treat ESR1-mutated metastatic...
biracell-logo-new.png
BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com
April 21, 2021 08:00 ET | Briacell Therapeutics Corp.
AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Bill Williams, M.D., President and CEO of BriaCell Therapeutics...
Atyr_Logo.png
aTyr Pharma Presents Preclinical Research Showing Effects of ATYR2810 in Lung and Breast Cancer at the 2021 AACR Virtual Annual Meeting
April 09, 2021 08:00 ET | aTyr Pharma, Inc.
Findings demonstrate tumor inhibitory effects of ATYR2810 when used as a monotherapy or in combination with chemotherapy in models of non-small cell lung cancer. ATYR2810 used in combination with...
arvinas logo.jpg
Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
April 05, 2021 16:30 ET | Arvinas Inc.
NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Join the One Billion Steps Challenge and STEP UP for Breast Cancer Research
March 30, 2021 10:00 ET | The Breast Cancer Society of Canada
SARNIA, Ontario, March 30, 2021 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) announced today the 30th anniversary of their annual Mother’s Day Walk, now the One Billion Steps...